Descrizione del progetto
Trattare il diabete con micropompe a pellicola sottile
Una rivoluzionaria micropompa a pellicola sottile può essere utilizzata come sistema innovativo nei dispositivi indossabili per il rilascio di insulina, destinati al trattamento del diabete. Proprio questa è la nuova tecnologia del progetto PRISMA, finanziato dall’UE. Grazie all’integrazione della micropompa di PRISMA nelle pompe cerotto per l’infusione di insulina, vengono affrontate le tre maggiori sfide legate a questo trattamento salvavita: le dimensioni, l’accuratezza della somministrazione del farmaco e il consumo energetico. L’obiettivo a lungo termine del progetto è permettere la realizzazione di sistemi per la somministrazione multifarmaco, trasformando il trattamento multiormone in realtà. Attualmente, l’obiettivo principale è convalidare la pompa e il suo processo di fabbricazione in un ambiente operativo reale.
Obiettivo
PRISMA is a revolutionary thin-film micropump realized with novel ceria-based oxides actuating materials in the frame of the FET-OPEN BioWings project, which can be used as an innovative pumping system in wearable insulin delivery devices for the treatment of diabetes. The integration of the PRISMA micropump in insulin patch pumps addresses the 3 most important pain points that still keep the vast majority of diabetic patients away from this life-saving treatment:
1) Size, which is more than two orders of magnitude smaller than state of the art.
2) Higher drug delivery accuracy within the ?5% range ensures the highest therapeutic efficacy.
3) drastic reduction in energy consumption.
Besides the short-term vision to realise extremely compact and accurate patch pumps, the long term goal is to allow the realisation of multi-drug delivery systems, making real the much-lauded multi-hormone treatment.
The main objective of this project is to validate the pump and its manufacturing process in a real operating environment, proving to system integrators that all specifications are consistently met to pave the way for the post-project system integration and clinical validation. This will pave the way to the launch of a startup company that will take care of the final steps of the development roadmap and will establish long-term cooperation agreements with prominent medical device manufacturers for the integration of PRISMA in next-generation single and multi-hormone smart patches.
Campo scientifico
Parole chiave
Programma(i)
- HORIZON.3.1 - The European Innovation Council (EIC) Main Programme
Invito a presentare proposte
HORIZON-EIC-2021-TRANSITIONOPEN-01
Vedi altri progetti per questo bandoMeccanismo di finanziamento
HORIZON-EIC - HORIZON EIC GrantsCoordinatore
2800 Kongens Lyngby
Danimarca